Sentences with phrase «global program provides»

Not exact matches

While the subject of China's emerging military is vast, there are several standout defense aerospace programs that provide an insight into China's global motives.

Cardone has provided sales - training programs to large global companies and authored several books on sales strategies, from closing more deals to dominating your market.

To address this changing market, Laureate will provide $ 13 million to help Thunderbird create new online and undergraduate programs, while also expanding its global footprint.

When customers buy (PRODUCT) RED products, Apple donates a portion of the proceeds to the Global Fund HIV / AIDS grants that provide a range of programs to eradicate AIDS or help people who have been affected by AIDS.

• The Women at Microsoft employee resource group runs a global conference for women employees and provides mentorship and STEM training to young girls through programs like GirlSpark, DigiGirlz Day, and High Tech Camps.

CNBC has a vast portfolio of digital products across a variety of platforms including: CNBC.com; CNBC PRO, the premium, integrated desktop / mobile service that provides live access to CNBC programming, exclusive video content and global market data and analysis; a suite of CNBC mobile products including the CNBC Apps for iOS, Android and Windows devices; and additional products such as the CNBC App for the Apple Watch and Apple TV.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«Having access to this type of highly coveted content on Twitter will not only offer our users a unique programming schedule which will deepen their engagement with our platform but will also provide our sponsors with a value proposition that few other partners can bring to the table,» said Adam Bain, president of global revenue for Twitter in a press release.

NextAI is a global innovation program for artificial intelligence - related ventures, and talented teams from around the world are invited to Canada to leverage the nation's leadership in AI and are provided with capital, mentorship, education and networking opportunities.

These include CNBC.com, the online destination for global business; CNBC PRO, the premium, integrated desktop / mobile service that provides real - time global market data and live access to CNBC global programming; and a suite of CNBC Mobile products including the CNBC Real - Time iPhone and iPad Apps.

The Carnegie Europe Program in Washington provides insight and analysis on political and security developments within Europe, transatlantic relations, and Europe's global role.

Hosted by David Westin, Jonathan Ferro and Alix Steel, Bloomberg's morning program brings viewers the latest in business and finance, providing unique, global insights into where industry and markets are headed.

The program provides traveler enrollment in TSA Precheck and in Global Entry, travel management company hours align with peak travel times and the travel program takes an omnichannel approach to accessing TMC support: telephone, online, mobile and chat.

Austin is actively engaged in the Company's 5by20 Global initiative to empower five million women entrepreneurs by 2020 and is a past participant in Coca - Cola's Women in Leadership Program, which is designed to provide key female talent an opportunity for accelerated development.

The story does not end with EV subsidies either as Tesla has provided very generous residual buyback programs in key global markets like Hong Kong, which has very generous government incentives at the front end (fully detailed in the legacy post below) putting a Tesla Model S pricing nearly on top of a gas powered Honda Civic and well below a Mercedes entry model.

The international feedback loop of global central bank QE programs has provided the SNB with a massive windfall.

The Global Trade Strategy is designed to help Ontario businesses benefit from the global economy, and provides a framework for the province's role to ensure that programs, policies and international trade agreements reflect the interests of our Province's businesses and woGlobal Trade Strategy is designed to help Ontario businesses benefit from the global economy, and provides a framework for the province's role to ensure that programs, policies and international trade agreements reflect the interests of our Province's businesses and woglobal economy, and provides a framework for the province's role to ensure that programs, policies and international trade agreements reflect the interests of our Province's businesses and workers.

NKF provides a fully integrated platform of services including leasing advisory, global corporate services, investment sales and capital markets, consulting, program and project management, property and facilities management and valuation services.

«Our Centers of Excellence program provide members with a unique forum to start development opportunities for minority businesses and corporate members alike,» said NMSDC Chairman Joe Hinrichs, who also is president, Global Operations at Ford Motor Company.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

- «Programming, advisory services, technical assistance, training and capacity development: carrying out catalytic, targeted and multisectoral programming; providing advisory services worldwide for the effective implementation of the commitments and norms adopted at the global level in the area of gender...Programming, advisory services, technical assistance, training and capacity development: carrying out catalytic, targeted and multisectoral programming; providing advisory services worldwide for the effective implementation of the commitments and norms adopted at the global level in the area of gender...programming; providing advisory services worldwide for the effective implementation of the commitments and norms adopted at the global level in the area of gender...» [6]

«Through UniPro, we can provide local market sensitivity with national clout; purchasing power, global sourcing, and an array of programs and services.»

We provide full service frozen fruit programs to some of the most respected and recognized global brands, such as Kirkland Signature, McDonalds, Great Value, Wild Oats, Starbucks, Market Pantry, Jamba Juice, O Organics and Safeway.

Support for the Global Food and Agriculture Program is generously provided by the Bill & Melinda Gates Foundation.

The program provides opportunities for U.S. producers of all sizes to connect with qualified global buyers — online and in - person — who are seeking to meet their customers» growing demand for USDA organic products.

I love that they pledge a portion of their yearly profits to global programs that bolster education programs for children, build schools, and provide clothes and food to those in need.

The Global Rice Science Partnership (GRiSP) or the CGIAR Research Program on Rice, provides a single strategic plan and unique new partnership platform for impact - oriented rice research for development; it is designed to more effectively solve development challenges.

«Through UniPro, we can provide local market sensitivity with national clout, purchasing power, global sourcing and an array of programs and services,» Meyer adds.

LDEI Atlanta provides thousands of dollars of funding and numerous volunteer hours to local organizations each year, focused on helping organizations working in the areas of: green tables / farming, global culinary initiatives, the culinary community and programs that teach cooking, nutrition or support anti-hunger work.

SCOTTSDALE, Ariz., May 5, 2016 / PRNewswire / — RiceBran Technologies (NASDAQ: RIBT and RIBTW)(the «Company» or «RBT»), a global leader in the production and marketing of value added products derived from rice bran, announced today that it has entered into two agreements: a Memorandum of Understanding (MOU) with non-profit The Jack Brewer Foundation (JBF Worldwide) to develop rice bran based supplemental feeding programs currently assisted by JBF Worldwide at orphanages in Malawi and Haiti; and a business development agreement with Brewer + Associates Consulting, LLC (B+A) to collaborate on the planned launch of a new line of sports nutrition products with a portion of profits earmarked to provide rice bran based meal supplements for feeding programs covered by the MOU.

In 2015, we migrated to a Global Food Safety Initiative (GFSI) based program in an effort to ensure the very highest attention to the safety and security of the products we provide.

Our tours support global conservation work while also providing important funding for our conservation programs in Massachusetts.

Spotlight: Replacement Feeding: Transition to Replacement Feeding by HIV - Positive Women Who Breastfeed is a publication by LINKAGES: Breastfeeding, LAM, Related Complementary Feeding, and Maternal Nutrition Program, and was made possible through support provided to the Academy for Educational Development (AED) by the Bureau for Global Health of the United States Agency for International Development (USAID), under the terms of Cooperative Agreement No.

Breastfeeding and Maternal Nutrition Frequently Asked Questions (FAQ) is a publication by LINKAGES: Breastfeeding, LAM, Related Complementary Feeding, and Maternal Nutrition Program, and was made possible through support provided to the Academy for Educational Development (AED) by the Bureau for Global Health of the United States Agency for International Development (USAID), under the terms of Cooperative Agreement No.

This FAQ Sheet is a publication by LINKAGES: Breastfeeding, LAM, Complementary Feeding, and Maternal Nutrition Program, and was made possible through support provided to the Academy for Educational Development (AED) by the Bureau for Global Health of the United States Agency for International Development (USAID), under the terms of Cooperative Agreement No.

Spotlight: PMTCT: Reducing Mother - to - Child Transmission of HIV among Women who Breastfeed is a publication by LINKAGES: Breastfeeding, LAM, Related Complementary Feeding, and Maternal Nutrition Program, and was made possible through support provided to the Academy for Educational Development (AED) by the Bureau for Global Health of the United States Agency for International Development (USAID), under the terms of Cooperative Agreement No.

The public - private initiative was orchestrated by the Niagara Global Tourism Institute, a program established by NU in 2014 with grant funding provided through NYPA's Power Proceeds program, as recommended by the Western New York Power Proceeds Allocation Board.

She handled day - to - day aspects for two federally - funded programs, GET SET (Global Education for Tomorrow in Science, Engineering, and Technology) which engaged students, teachers, and parents in a suite of learning activities designed to increase student interest in pursuit of advanced course - taking, and careers in engineering and other STEM areas, and DC ACTS (DC Advancing Competencies in Technology and Science), which provided CEU's from George Washington University to teachers furthering their science education and teaching pedagogy.

The training offered through this program will expand the global health workforce and provide fellows an opportunity to gain practical, first - hand experience on the front lines of global public health.

The Global Change Education Program provides opportunities to participate in research areas related to global cGlobal Change Education Program provides opportunities to participate in research areas related to global cglobal change.

This important program has helped improve academic achievement and continues to provide our schools and teachers with the resources to prepare our students for the global economy.

The committee report says the bill provides «strong support... for basic science programs, which provide the foundation for the new energy technologies that are vital to maintaining our global competitiveness and ensuring our country's long - term prosperity, but that are often too high - risk to receive the attention of the private sector.

The 12 feature articles provide concrete examples of programs that are working effectively on the ground, reflect on global progress madeand define a way forward.

While STEGHs can provide students with important global and cross-cultural education, the authors say they believe a paradigm shift is needed to ensure that the programs benefit both the trainees and the communities they visit.

A government program to provide health insurance for catastrophic illness to households below the poverty line in Karnataka, lowered both mortality rates and out - of - pocket expenses for the residents, according to a recent evaluation published in the leading global health journal The BMJ.

Brad provides scientific and programmatic leadership for NHLBI's Hypertension Outcomes for T4 REsearch within Lower Middle - Income Countries and T4 Translation Research Capacity Building Initiative in Low Income Countries programs, as well as institutional oversight of the Fogarty Global Health Training Program.

To provide postdocs from developing countries with an incentive to go back home upon completion of their training, FIC has launched the Global Health Research Initiative Program (GRIP) for New Foreign Investigators.

The idea is to provide dedicated funding to the U.S. Global Change Research Program to conduct such assessments, which would then form a base for government and the private sector to plan for the effects of climate change.

Through world - renowned publications, meetings and membership programs, OSA provides quality research, inspired interactions and dedicated resources for its extensive global network of professionals in optics and photonics.

-- The President shall establish an interagency United States Global Change Research Program to improve understanding of global change, to respond to the information needs of communities and decisionmakers, and to provide periodic assessments of the vulnerability of the United States and other regions to global and regional climate cGlobal Change Research Program to improve understanding of global change, to respond to the information needs of communities and decisionmakers, and to provide periodic assessments of the vulnerability of the United States and other regions to global and regional climate cglobal change, to respond to the information needs of communities and decisionmakers, and to provide periodic assessments of the vulnerability of the United States and other regions to global and regional climate cglobal and regional climate change.